Metraipolis › archive › dc_76cf8b978474
SGLT2 Inhibitors Between Benefits and Euglycemic Ketoacidosis: A Concise Review — Europe PMC PMID:42352947
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42352947
- DOI
- 10.3390/ijms27125224
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-31T15:56:41.053Z
- SHA-256 of the archived text
a2d246f59342ccd05da96fde4a16b32c0921a917dada7955613d6c406dd856f9- Stable URL of this page
https://metraipolis.com/documento/dc_76cf8b978474
How to cite
SGLT2 Inhibitors Between Benefits and Euglycemic Ketoacidosis: A Concise Review — Europe PMC PMID:42352947 — Europe PMC (en), https://europepmc.org/article/MED/42352947 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_76cf8b978474 (Metraipolis archive dc_76cf8b978474, sha256 a2d246f59342ccd05da96fde4a16b32c0921a917dada7955613d6c406dd856f9)
BibTeX
@misc{dc76cf8b978474,
title = {SGLT2 Inhibitors Between Benefits and Euglycemic Ketoacidosis: A Concise Review — Europe PMC PMID:42352947},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42352947},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_76cf8b978474; sha256 a2d246f59342ccd05da96fde4a16b32c0921a917dada7955613d6c406dd856f9},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42352947. Agents can read the archived copy with the MCP tool read_document.